Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Endocrinology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Endocrinology Other
    Use of Antipsychotic Medications by Children and Adolescents Associated With Significant Weight Gain - (DGNews)
    Calcium Protocol Prevents Calcium Deficit After Parathyroidectomy: Presented at ACS - (DGDispatch)
    Ratio of Thyroglobulin to Serum Thyrotropin May Be Tumour Marker for Thyroid Cancer: Presented at AAO-HNSF - (DGDispatch)
    No Relationship Found Between Intraoperative Parathyroid Hormone Levels and Parathyroid Adenoma Mass Size: Presented at AAO-HNSF - (DGDispatch)
    Anaemic Patients With MDS Benefit From Erythropoietin, Myeloid Growth Factor Hormones - (DGNews)

    News archive

     Recent webcasts/CME - Endocrinology Other
    Topics in Male Hypogonadism
    Multidisciplinary Approach to Management of Neuroendocrine Tumors

    Webcasts/CME archive

     Recent cases - Endocrinology Other
      Utility of Follow-Up of 131I-MIBG Scintigraphy to Screen Pheochromocytoma
      Effects of Growth Hormone Reduction in a Patient with Polycystic Ovary Syndrome Complicated with Acromegaly
      Adrenocortical Carcinoma Secreting Cortisol, Androgens and Aldosterone: A Case Report
      Pheochromocytoma in an Accessory Adrenal Gland: A Case Report
      A Novel Heterozygous Mutation of Steroidogenic Factor-1 (SF-1/Ad4BP) Gene (NR5A1) in a 46, XY Disorders of Sex Development (DSD) Patient without Adrenal Failure

      Cases archive
        




      my personal edition > endocrinology other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Metformin and Carbohydrate-Modified Diet May Help Sustain Weight Loss

      A DGReview of :"Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (syndrome w)"
      Heart Disease

      12/16/2003
      By Jill Taylor


      The combined regimen of metformin and a carbohydrate-modified diet promotes long-term weight stabilisation in obese, middle-aged, nondiabetic women with documented insulin abnormalities, say American researchers.

      The majority of patients who successfully lose weight in traditional dietary programs regain the weight within 2 to 4 years, and few treatment strategies for sustained weight reduction exist that are effective, safe, and acceptable.

      In a previous study, women with Syndrome W, an early variant of the Metabolic Syndrome, achieved significant weight loss with metformin and a carbohydreate-modified, hypocaloric, low-glycaemic-index diet.

      To assess the long-term efficacy this regimen, Harriette R Mogul, MD, MPH, and colleagues of New York Medical College, Valhalla, United States, conducted a retrospective analysis of 21 study participants who returned for medication renewal and annual surveillance visits.

      All patients included in the analysis had achieved a 1-year weight loss of more than 10% or body mass index (BMI) normalisation. Baseline characteristics included an average age of 55.2 years, BMI of 34.2 kg/m2, and weight of 196.9 lbs.

      The researchers observed weight maintenance at the final (2 to 4 years) follow-up visit in 90.5% of the women, with the mean weight at final follow-up highly correlated with mean weight at 1-year protocol completion.

      Furthermore, a significant and robust decline in fasting insulin (-27.5% -43.8%, P < .002) was observed at all follow-up visits. Metformin was well tolerated, without reported side effects or electrolyte imbalance.

      Although researchers acknowledge clear methodologic limitation, they hope that the study findings will encourage clinicians to contemplate the potential viability of defining and treating insulin abnormalities in euglycemic women with midlife weight gain who fail to respond to other obesity interventions.

      "We believe this effective novel obesity treatment, which is easily implemented in a clinical setting, could have important implications for women with Syndrome W, and quite possibly for other subpopulations of obese nondiabetic Americans with progressive weight gain and documented hyperinsulinemia," they conclude.


      Heart Dis 2003 Nov-Dec;5:6:384-92. "Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (syndrome w)"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send